organization · Reporting owner
Pardeep Nijhawan Medicine Professional Corp
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Edesa Biotech, Inc.EDSA · Entity 7223 | 10% owner | March 25, 2024 | March 25, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Edesa Biotech, Inc.
Report date March 25, 2024 · Filed March 25, 2024
Jointly reported with Nijhawan Pardeep
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectHeld by Pardeep Nijhawan Medicine Professional Corporation | 341,702 |
Reported balance
After 2024-03-25 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-03-25 · Purchase · Acquired 5,000 · Balance 341,702 F1: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | Direct | 107,810 |
Reported balance
Holding disclosure · report date 2024-03-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 107,810 |
| Common SharesSEC Table I · non-derivative | IndirectHeld by The New Nijhawan Family Trust 2015 | 32,609 |
Reported balance
Holding disclosure · report date 2024-03-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 32,609 F2: Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by The Digestive Health Clinic Inc | 32,013 |
Reported balance
Holding disclosure · report date 2024-03-25 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 32,013 F1: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | IndirectHeld by 1968160 Ontario Inc | 53,104 |
Reported balance
Holding disclosure · report date 2024-03-25 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 53,104 F1: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2: Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2024 Filed Mar 25, 2024 19:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $4.00 | $20,000.00 |
DisclosureSEC source: 0001654954-24-003606 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 341,702 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 9 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 114,131 Underlying: Common Share · 114,131 shares Expires not disclosed F4 · security: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F4 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F4 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 8 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 114,131 Underlying: Common Shares · 114,131 shares Expires not disclosed F4 · security: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F4 · derivative.exercise_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F4 · derivative.expiration_date: Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 7 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 114,131 Underlying: Common Share · 114,131 shares Expires not disclosed F3 · security: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 114,131 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · derivative · entry 6 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 114,131 Underlying: Common Shares · 114,131 shares Expires not disclosed F3 · security: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F3 · derivative.exercise_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F3 · derivative.expiration_date: Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 228,262 | $1.13 | $256,794.75 |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 228,262 F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 15:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 228,262 | $1.13 | $256,794.75 |
DisclosureSEC source: 0001654954-22-014745 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,356,914 F1 · price: The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:38 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 20,000 | $1.60 | $32,078.00 |
DisclosureSEC source: 0001654954-22-009259 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594,812 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 27, 2022 Filed May 31, 2022 09:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $1.92 | $9,599.00 |
DisclosureSEC source: 0001654954-22-007684 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,812 Read SEC document |
| May 24, 2022 Filed May 25, 2022 12:13 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $1.80 | $3,599.60 |
DisclosureSEC source: 0001654954-22-007509 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,812 Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 10:56 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $2.99 | $5,971.60 |
DisclosureSEC source: 0001654954-22-004413 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,812 Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 10:52 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.05 | $6,098.20 |
DisclosureSEC source: 0001654954-22-004245 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,812 Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 12:47 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.02 | $6,033.60 |
DisclosureSEC source: 0001654954-22-004118 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,812 Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 10:27 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.85 | $7,699.20 |
DisclosureSEC source: 0001654954-22-003483 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,603 | $3.26 | $5,232.19 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,812 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 11:26 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 397 | $3.25 | $1,290.17 |
DisclosureSEC source: 0001654954-22-003409 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,209 Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 11:17 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $2.80 | $5,598.00 |
DisclosureSEC source: 0001654954-22-003224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,812 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $3.06 | $15,294.50 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,812 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 13:59 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $3.18 | $6,357.60 |
DisclosureSEC source: 0001654954-22-003095 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,812 Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 11:10 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,500 | $3.05 | $4,569.60 |
DisclosureSEC source: 0001654954-22-002850 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,812 Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 11:44 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 3,000 | $5.25 | $15,750.00 |
DisclosureSEC source: 0001654954-21-003334 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,312 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 14:43 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 5,000 | $5.16 | $25,800.00 |
DisclosureSEC source: 0001654954-21-003274 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,312 Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon share warrants (Right to buy) · Derivative | 4,628 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 0 Underlying: Common shares · 4,628 shares Expires 2020-11-08 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 10:00 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon Shares | 4,628 | $4.00 | $18,512.00 |
DisclosureSEC source: 0001654954-20-011925 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,128,652 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 09:23 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | OtherCommon Shares | 371,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-20-010224 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by 1968160 Ontario Inc. Disclosed balance after: 371,727 F2 · price: Pardeep Nijhawan acquired 100% of the capital stock of 1968160 Ontario Inc. which holds 371,727 common shares of the issuer, pursuant to the foreign equivalent of a domestic relations order. F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| May 26, 2020 Filed May 28, 2020 12:19 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 3,000 | $2.98 | $8,939.10 |
DisclosureSEC source: 0001654954-20-006029 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation (1) Disclosed balance after: 2,124,024 F1 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 29, 2020 Filed Mar 29, 2021 13:02 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 2,000 | $5.23 | $10,460.00 |
DisclosureSEC source: 0001654954-21-003384 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · Director · Chief Executive Officer · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,312 Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.90 | $1,897.50 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,121,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.83 | $1,828.00 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,120,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.90 | $1,897.80 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 3 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,119,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.86 | $1,859.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 2 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,118,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 10:34 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | PurchaseCommon Shares | 1,000 | $1.89 | $1,889.90 |
DisclosureSEC source: 0001654954-20-002851 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,117,024 F1 · ownership.nature: Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 4,628 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 5 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 4,628 Underlying: Common Shares · 4,628 shares Expires 2020-11-08 F4 · security: Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Share Warrants (Right to Buy) · Derivative | 6,942 | Not disclosed Strike: $4.80 | Not disclosed |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · derivative · entry 4 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 6,942 Underlying: Common Shares · 6,942 shares Expires 2023-07-08 F3 · security: Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023. F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 21:42 UTC | Edesa Biotech, Inc. EDSA · Entity 7223 | GrantCommon Shares | 9,255 | $4.11 | $38,038.05 |
DisclosureSEC source: 0001654954-20-000314 · section16.xml · nonDerivative · entry 1 Nijhawan Pardeep · CIK 0001777962 · Director · Chief Executive Officer · 10% owner Pardeep Nijhawan Medicine Professional Corp · CIK 0001780021 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Pardeep Nijhawan Medicine Professional Corporation Disclosed balance after: 2,116,024 F1 · price: The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share. F2 · ownership.nature: Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.